References

  1. Schierhout G, Roberts I: Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials.

    BMJ 1998, 316:961-964. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  2. Cochrane Injuries Group Albumin Reviewers: Human albumin administration in critically ill patients: systematic review of randomised controlled trials.

    BMJ 1998, 317:235-240. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  3. Choi PT, Yip G, Quinonez LG, Cook DJ: Crystalloids vs. colloids in fluid resuscitation: a systematic review.

    Crit Care Med 1999, 27:200-210. PubMed Abstract | Publisher Full Text OpenURL

  4. Roberts I, Edwards P, McLelland B: More on albumin. Use of human albumin in UK fell substantially when systematic review was published.

    BMJ 1999, 318:1214-1215. PubMed Abstract OpenURL

  5. Deitch EA: Animal models of sepsis and shock: a review and lessons learned.

    Shock 1998, 9:1-11. PubMed Abstract OpenURL

  6. Michie HR: The value of animal models in the development of new drugs for the treatment of the sepsis syndrome.

    J Antimicrob Chemother 1998, 41 (suppl A):47-49. PubMed Abstract | Publisher Full Text OpenURL

  7. Mathiak G, Szewczyk D, Abdullah F, et al.: An improved clinically relevant sepsis model in the conscious rat.

    Crit Care Med 2000, 28:1947-1952. PubMed Abstract | Publisher Full Text OpenURL

  8. Abraham E, Wunderink R, Silverman H, et al.: Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial.

    JAMA 1995, 273:934-941. PubMed Abstract | Publisher Full Text OpenURL

  9. Reinhart K, Wiegand-Lohnert C, Grimminger F, et al.: Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

    Crit Care Med 1996, 24:733-742. PubMed Abstract | Publisher Full Text OpenURL

  10. Teng NN, Kaplan HS, Hebert JM, et al.: Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies.

    Proc Natl Acad Sci USA 1985, 82:1790-1794. PubMed Abstract OpenURL

  11. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al.: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial.

    N Engl J Med 1991, 324:429-436. PubMed Abstract OpenURL

  12. Quezado ZM, Natanson C, Alling DW, et al.: A controlled trial of HA-1A in a canine model of gram-negative septic shock.

    JAMA 1993, 269:2221-2227. PubMed Abstract | Publisher Full Text OpenURL

  13. McCloskey RV, Straube RC, Sanders C, et al.: Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial.

    Ann Intern Med 1994, 121:1-5. PubMed Abstract | Publisher Full Text OpenURL

  14. Rennick DM, Fort MM: Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-)) mice and intestinal inflammation.

    Am J Physiol Gastrointest Liver Physiol 2000, 278:G829-G833. PubMed Abstract | Publisher Full Text OpenURL

  15. Piper RD, Cook DJ, Bone RC, Sibbald WJ: Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis.

    Crit Care Med 1996, 24:2059-2070. PubMed Abstract | Publisher Full Text OpenURL

  16. Drews J, Ryser S: The role of innovation in drug development.

    Nat Biotechnol 1997, 15:1318-1319. PubMed Abstract OpenURL

  17. Cook DJ, Sackett DL, Spitzer WO: Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis.

    J Clin Epidemiol 1995, 48:167-171. PubMed Abstract | Publisher Full Text OpenURL

  18. Stroup DF, Berlin JA, Morton SC, et al.: Meta-analysis of observational studies in epidemiology: a proposal for reporting.

    JAMA 2000, 283:2008-2012. PubMed Abstract | Publisher Full Text OpenURL

  19. Freedman LS: Meta-analysis of animal experiments on dietary fat intake and mammary tumours.

    Stat Med 1994, 13:709-718. PubMed Abstract OpenURL

  20. Freedman LS, Clifford CK: Meta-analysis of animal experiments: elucidating relationships between dietary fat and mammary tumor development in rodents.

    Adv Exp Med Biol 1994, 364:93-100. PubMed Abstract OpenURL

  21. McKnight B: Considerations in the conduct of meta-analysis using data from animal carcinogenicity experiments.

    IARC Sci Publ 1992, 116:557-569. PubMed Abstract OpenURL

  22. Valberg PA, Crouch EA: Meta-analysis of rat lung tumors from lifetime inhalation of diesel exhaust.

    Environ Health Perspect 1999, 107:693-699. PubMed Abstract | Publisher Full Text OpenURL

  23. Perna A, Remuzzi G: Abnormal permeability to proteins and glomerular lesions: a meta-analysis of experimental and human studies.

    Am J Kidney Dis 1996, 27:34-41. PubMed Abstract OpenURL

  24. Benignus VA, Boyes WK, Bushnell PJ: A dosimetric analysis of behavioral effects of acute toluene exposure in rats and humans.

    Toxicol Sci 1998, 43:186-195. PubMed Abstract | Publisher Full Text OpenURL

  25. Craig JC, Wheeler DM, Irwig L, Howman-Giles RB: How accurate is dimercaptosuccinic acid scintigraphy for the diagnosis of acute pyelonephritis? A meta-analysis of experimental studies.

    J Nucl Med 2000, 41:986-993. PubMed Abstract OpenURL

  26. Bardo MT, Rowlett JK, Harris MJ: Conditioned place preference using opiate and stimulant drugs: a meta-analysis.

    Neurosci Biobehav Rev 1995, 19:39-51. PubMed Abstract | Publisher Full Text OpenURL

  27. Kelley G: Mechanical overload and skeletal muscle fiber hyperplasia: a meta-analysis.

    J Appl Physiol 1996, 81:1584-1588. PubMed Abstract | Publisher Full Text OpenURL

  28. Linde K, Jonas WB, Melchart D, et al.: Critical review and meta-analysis of serial agitated dilutions in experimental toxicology.

    Hum Exp Toxicol 1994, 13:481-492. PubMed Abstract OpenURL

  29. Wilson MA, Chou MC, Spain DA, et al.: Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis.

    J Trauma 1996, 41:622-627. PubMed Abstract | Publisher Full Text OpenURL

  30. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure.

    Chest 1992, 101:1481-1483. PubMed Abstract OpenURL

  31. Doig GS, Martin CM, Sibbald WJ: Polymyxin-dextran antiendotoxin pretreatment in an ovine model of normotensive sepsis.

    Crit Care Med 1997, 25:1956-1961. PubMed Abstract | Publisher Full Text OpenURL

  32. Morisaki H, Bloos F, Keys J, et al.: Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep.

    J Appl Physiol 1994, 77:1507-1518. PubMed Abstract OpenURL

  33. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis.

    JAMA 1993, 269:3024-3029. PubMed Abstract | Publisher Full Text OpenURL

  34. Silverman HJ, Tuma P: Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions.

    Chest 1992, 102:184-188. PubMed Abstract OpenURL

  35. Fitzgerald RD, Martin CM, Dietz GE, et al.: Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats.

    Crit Care Med 1997, 25:726-732. PubMed Abstract | Publisher Full Text OpenURL